Literature DB >> 6574228

Rapidly progressive periodontitis. A distinct clinical condition.

R C Page, L C Altman, J L Ebersole, G E Vandesteen, W H Dahlberg, B L Williams, S K Osterberg.   

Abstract

We report radiographic, clinical, historical, and laboratory observations on seven patients selected to illustrate the features and characteristics of rapidly progressive periodontitis, with the aim of establishing this disease as a distinct clinical entity. This form of periodontitis is seen most commonly in young adults in their twenties, but it can occur in postpubertal individuals up to approximately 35 years of age. During the active phase, the gingival tissues are extremely inflamed and there is hemorrhage, proliferation of the marginal gingiva, and exudation. Destruction is very rapid, with loss of much of the alveolar bone occurring within a few weeks or months. This phase may be accompanied by general malaise, weight loss, and depression, although these symptoms are not seen in all patients. The disease may progress, without remission, to tooth loss, or alternatively, it may subside and become quiescent with or without therapy. The quiescent phase is characterized by the presence of clinically normal gingiva that may be tightly adapted to the roots of teeth with very advanced bone loss and deep periodontal pockets. The quiescent phase may be permanent, it may persist for an indefinite period, or the disease activity may return. Most patients with rapidly progressive periodontitis have serum antibodies specific for various species of Bacteroides, Actinobacillus, or both, and manifest defects in either neutrophil or monocyte chemotaxis. Affected patients generally respond favorably to treatment by scaling and open or closed curettage, especially when accompanied by standard doses of antibiotics for conventional time periods. A small minority of patients do not respond to any treatment, including antibiotics, and the disease progresses inexorably to tooth loss even in the presence of aggressive periodontal therapy and maintenance. At the present time it is not possible to distinguish prior to treatment which individuals will respond to therapy and which will not.

Entities:  

Mesh:

Year:  1983        PMID: 6574228     DOI: 10.1902/jop.1983.54.4.197

Source DB:  PubMed          Journal:  J Periodontol        ISSN: 0022-3492            Impact factor:   6.993


  22 in total

1.  Detection of unculturable bacteria in periodontal health and disease by PCR.

Authors:  R Harper-Owen; D Dymock; V Booth; A J Weightman; W G Wade
Journal:  J Clin Microbiol       Date:  1999-05       Impact factor: 5.948

Review 2.  Periodontitis for medical practitioners.

Authors:  T L Watts
Journal:  BMJ       Date:  1998-03-28

Review 3.  Outcomes of implant therapy in patients with a history of aggressive periodontitis. A systematic review and meta-analysis.

Authors:  Charis Theodoridis; Andreas Grigoriadis; Georgios Menexes; Ioannis Vouros
Journal:  Clin Oral Investig       Date:  2016-12-24       Impact factor: 3.573

4.  Alveolar Bone Protection by Targeting the SH3BP2-SYK Axis in Osteoclasts.

Authors:  Mizuho Kittaka; Tetsuya Yoshimoto; Collin Schlosser; Robert Rottapel; Mikihito Kajiya; Hidemi Kurihara; Ernst J Reichenberger; Yasuyoshi Ueki
Journal:  J Bone Miner Res       Date:  2019-10-24       Impact factor: 6.741

5.  Molecular epidemiology of oral treponemes associated with periodontal disease.

Authors:  A Moter; C Hoenig; B K Choi; B Riep; U B Göbel
Journal:  J Clin Microbiol       Date:  1998-05       Impact factor: 5.948

6.  Serum antibody in Actinobacillus actinomycetemcomitans-infected patients with periodontal disease.

Authors:  J L Ebersole; M N Sandoval; M J Steffen; D Cappelli
Journal:  Infect Immun       Date:  1991-05       Impact factor: 3.441

7.  Avidity of antibody responses to Actinobacillus actinomycetemcomitans in periodontitis.

Authors:  D S O'Dell; J L Ebersole
Journal:  Clin Exp Immunol       Date:  1995-08       Impact factor: 4.330

8.  Role of psychotherapy in managing a case of generalised aggressive periodontitis.

Authors:  D Priyadarshini; Prasad Nadig; Neeraj Deshpande; Anshula Deshpande
Journal:  BMJ Case Rep       Date:  2014-07-17

9.  Human immune responses to oral microorganisms: patterns of systemic antibody levels to Bacteroides species.

Authors:  J L Ebersole; M A Taubman; D J Smith; D E Frey
Journal:  Infect Immun       Date:  1986-02       Impact factor: 3.441

10.  Opsonic antibody activity against Actinobacillus actinomycetemcomitans in patients with rapidly progressive periodontitis.

Authors:  K Sjöström; R Darveau; R Page; C Whitney; D Engel
Journal:  Infect Immun       Date:  1992-11       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.